Preliminary results of immune modulating antibody MDV9300 (pidilizumab) treatment in children with diffuse intrinsic pontine glioma. [electronic resource]
Producer: 20190130Description: 189-195 p. digitalISSN:- 1573-7373
- Adolescent
- Antibodies, Monoclonal -- therapeutic use
- Antineoplastic Agents, Immunological -- therapeutic use
- Brain Stem Neoplasms -- drug therapy
- Child
- Child, Preschool
- Combined Modality Therapy
- Disease Progression
- Female
- Glioma -- drug therapy
- Humans
- Male
- Progression-Free Survival
- Prospective Studies
- Survival Analysis
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.